Britannia Life Sciences Inc.

BLAB.CNCNQHealthcare● Active

$0.09

+$0.00(+0.00%)

Market Cap$13791619

P/E Ratio—

52W High$0.14

52W Low$0.06

Avg Volume105K

Open$0.09

Beta-0.08

Earnings Financials Revenue

Britannia Life Sciences Inc. (BLAB.CN) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

BLAB.CN · earnings · updated Jun 8, 2026

Latest Earnings

Q4 FY2023Report Date: Dec 31, 2023

EPS Actual

$0.00

Revenue

$0.00B

Fiscal Period

Q4 FY2023

FY ends December

Report Date

Dec 31, 2023

After Market Close

BLAB.CN reports quarterly as a CNQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

$0.37

Rev. $0.36B

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.$0.37

Rev. Est.$0.36B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q4 FY2023	Dec 31, 2023	—	$0.00	—	$0.00B	—	—
— Q3 FY2023	Sep 30, 2023	—	$0.00	—	$0.00B	—	—
— Q2 FY2023	Jun 30, 2023	—	$0.03	—	$0.00B	—	—
— Q1 FY2023	Mar 31, 2023	—	$0.00	—	$0.00B	—	—
— Q4 FY2022	Dec 31, 2022	—	-$0.00	—	$0.00B	—	—
— Q3 FY2022	Sep 30, 2022	—	$0.01	—	$0.00B	—	—
— Q2 FY2021	Jun 30, 2021	—	$0.01	—	$0.00B	—	—
— Q1 FY2021	Mar 31, 2021	—	$0.00	—	$0.00B	—	—

Q4 FY2023

Dec 31, 2023

EPS Actual

$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q3 FY2023

Sep 30, 2023

EPS Actual

$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q2 FY2023

Jun 30, 2023

EPS Actual

$0.03

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q1 FY2023

Mar 31, 2023

EPS Actual

$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q4 FY2022

Dec 31, 2022

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q3 FY2022

Sep 30, 2022

EPS Actual

$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q2 FY2021

Jun 30, 2021

EPS Actual

$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q1 FY2021

Mar 31, 2021

EPS Actual

$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

No analyst estimates available for BLAB.CN.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q4 FY2023	Dec 31, 2023	—	$0.08	$0.09	+13.33%
— Q3 FY2023	Sep 30, 2023	—	$0.07	$0.07	+7.69%
— Q2 FY2023	Jun 30, 2023	—	$0.12	$0.12	+0.00%
— Q1 FY2023	Mar 31, 2023	—	$0.10	$0.10	+0.00%
— Q4 FY2022	Dec 31, 2022	—	$0.07	$0.08	+14.29%
— Q3 FY2022	Sep 30, 2022	—	$0.13	$0.13	+0.00%
— Q2 FY2021	Jun 30, 2021	—	No price data	$0.27	—
— Q1 FY2021	Mar 31, 2021	—	No price data	$0.27	—

Q4 FY2023+13.33%

Report Date

Dec 31, 2023

EPS Beat/Miss

—

Price Before

$0.08

Price After

$0.09

Q3 FY2023+7.69%

Report Date

Sep 30, 2023

EPS Beat/Miss

—

Price Before

$0.07

Price After

$0.07

Q2 FY2023+0.00%

Report Date

Jun 30, 2023

EPS Beat/Miss

—

Price Before

$0.12

Price After

$0.12

Q1 FY2023+0.00%

Report Date

Mar 31, 2023

EPS Beat/Miss

—

Price Before

$0.10

Price After

$0.10

Q4 FY2022+14.29%

Report Date

Dec 31, 2022

EPS Beat/Miss

—

Price Before

$0.07

Price After

$0.08

Q3 FY2022+0.00%

Report Date

Sep 30, 2022

EPS Beat/Miss

—

Price Before

$0.13

Price After

$0.13

Q2 FY2021—

Report Date

Jun 30, 2021

EPS Beat/Miss

—

Price Before

—

Price After

$0.27

Q1 FY2021—

Report Date

Mar 31, 2021

EPS Beat/Miss

—

Price Before

—

Price After

$0.27

Beat Rate0 / 8 quarters

Largest Move+14.29% (Q4 FY2022)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Britannia Life Sciences Inc. (BLAB.CN) most recently reported earnings on December 31, 2023 for Q4 FY2023, posting EPS of $0.00 (in line with the analyst consensus of —). The next BLAB.CN earnings date is expected around September 1, 2026.

Each quarter, investors track BLAB.CN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BLAB.CN revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

BLAB.CN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

BLAB.CN earnings · 4 questions

Britannia Life Sciences Inc.'s next earnings report is expected around September 1, 2026. BLAB.CN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BLAB.CN historically reports after market close (AMC).

BLAB.CN earnings datewhen is BLAB.CN earningsBLAB.CN next earnings datewhen does BLAB.CN report earningsBLAB.CN earnings calendar

▸ Source: FMP · Britannia Life Sciences Inc. SEC filings · US GAAP · Britannia Life Sciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026